Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Squamous Cell Carcinoma of Head and Neck 1Prostatic Neoplasms 1Prostate Adenocarcinoma 1Oropharyngeal Neoplasms 1Cholangiocarcinoma 1Carcinoma, Squamous Cell 1

Interventions

Gemcitabine 5Cisplatin 5Oxaliplatin 4Magnetic Resonance Spectroscopy 4Leucovorin 4Fluorouracil 4durvalumab 3Taxes 3futibatinib 2fludarabine 2Specimen Handling 2Platinum 2Paclitaxel 2Nivolumab 2Irinotecan 2Folfox protocol 2Fluorodeoxyglucose F18 2Carboplatin 2Biopsy 21,2-diaminocyclohexaneplatinum II citrate 2zimberelimab 1ulixertinib 1tocilizumab 1tivozanib 1tislelizumab 1regorafenib 1pevonedistat 1pemigatinib 1pembrolizumab 1olutasidenib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Cholangiocarcinoma × Radiotherapy, Image-Guided × 30 days × Clear all
NCT02200042 2026-05-19

Radiation Therapy vs. Observation Following Gemcitabine and Cisplatin for Inoperable Localized Liver Cancer

NRG Oncology

Phase 3 Terminated
1 enrolled 5 charts
Gastrointestinal

Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡